drugset / Trial / NCT00696722

Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction

NCT00696722

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether atazanavir use is of influence on the endothelial dysfunction associated with type 2 diabetes mellitus.

Timeline

Start
2008-06
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified